Research Article

Identification and External Validation of a Transcription Factor-Related Prognostic Signature in Pediatric Neuroblastoma

Figure 4

Validation of the eight TF-based risk signatures in GEO cohort. (a) Kaplan–Meier survival analysis of the TF-based prognostic models. (b) Distribution of survival times of neuroblastoma patients. (c) Distribution of risk scores of neuroblastoma patients. (d) Area under the curve reflects the high prognostic accuracy of the TF-based signature. (e) Distribution of the expression values of TFs in the model.
(a)
(b)
(c)
(d)
(e)